Literature DB >> 20833383

Decreased proportion of peripheral blood vascular endothelial growth factor-expressing T and natural killer cells in preeclampsia.

Attila Molvarec1, Mika Ito, Tomoko Shima, Satoshi Yoneda, Gergely Toldi, Balázs Stenczer, Barna Vásárhelyi, János Rigó, Shigeru Saito.   

Abstract

OBJECTIVE: The purpose of this study was to determine the proportion of circulating T and natural killer (NK) cells that express intracellular vascular endothelial growth factor (VEGF) in women with preeclampsia compared to those with a normal pregnancy. STUDY
DESIGN: In all, 24 preeclamptic patients and 30 healthy pregnant women were involved in this case-control study. Intracellular VEGF expression of unstimulated lymphocytes was determined with flow cytometric examination.
RESULTS: In healthy pregnant women, the majority of both T and NK cells expressed VEGF in their cytoplasma (median, 79.9%; 25-75 percentile, 73.7-87.0 and median, 78.3%; 25-75 percentile, 64.1-85.3, respectively). Furthermore, CD4(+) helper and CD8(+) cytotoxic T cells showed a similar pattern of VEGF expression in normal pregnancy. However, the proportion of VEGF-expressing peripheral blood T (both helper and cytotoxic) and NK cells was markedly decreased in preeclampsia (for T cells: median, 51.6%; 25-75 percentile, 40.1-60.0; P < .001; for NK cells: median, 45.2%; 25-75 percentile, 27.4-64.0; P < .001).
CONCLUSION: Our results suggest decreased production of VEGF by circulating T and NK cells in preeclampsia, which might contribute to the development of the generalized endothelial dysfunction characteristic of the maternal syndrome of the disease.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20833383     DOI: 10.1016/j.ajog.2010.07.019

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Endothelial-derived hyperpolarization factor (EDHF) contributes to PlGF-induced dilation of mesenteric resistance arteries from pregnant rats.

Authors:  Maurizio Mandalà; Natalia Gokina; Carolyn Barron; George Osol
Journal:  J Vasc Res       Date:  2011-10-06       Impact factor: 1.934

2.  Immunometabolic adaptation and immune plasticity in pregnancy and the bi-directional effects of obesity.

Authors:  April Rees; Oliver Richards; Megan Chambers; Benjamin J Jenkins; James G Cronin; Catherine A Thornton
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

3.  Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia.

Authors:  Attila Molvarec; András Szarka; Szilvia Walentin; Gabriella Beko; István Karádi; Zoltán Prohászka; János Rigó
Journal:  Reprod Biol Endocrinol       Date:  2011-09-09       Impact factor: 5.211

Review 4.  Cellular immune responses in the pathophysiology of preeclampsia.

Authors:  Derek Miller; Kenichiro Motomura; Jose Galaz; Meyer Gershater; Eun D Lee; Roberto Romero; Nardhy Gomez-Lopez
Journal:  J Leukoc Biol       Date:  2021-04-13       Impact factor: 6.011

Review 5.  Biomarkers for the management of pre-eclampsia in pregnant women.

Authors:  Lakshmi Tanuja Petla; Rosy Chikkala; K S Ratnakar; Vijayalakshmi Kodati; V Sritharan
Journal:  Indian J Med Res       Date:  2013       Impact factor: 2.375

Review 6.  HLA Class Ib Molecules and Immune Cells in Pregnancy and Preeclampsia.

Authors:  Snezana Djurisic; Thomas Vauvert F Hviid
Journal:  Front Immunol       Date:  2014-12-23       Impact factor: 7.561

7.  Folic acid supplementation attenuates hyperhomocysteinemia-induced preeclampsia-like symptoms in rats.

Authors:  Jun Wang; Yan Cui; Jing Ge; Meijing Ma
Journal:  Neural Regen Res       Date:  2012-09-05       Impact factor: 5.135

Review 8.  Inflammatory pattern recognition receptors and their ligands: factors contributing to the pathogenesis of preeclampsia.

Authors:  Toshiyuki Sado; Katsuhiko Naruse; Taketoshi Noguchi; Shoji Haruta; Shozo Yoshida; Yasuhito Tanase; Takashi Kitanaka; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Inflamm Res       Date:  2011-03-06       Impact factor: 4.575

9.  Role of maternal serum interleukin 17 in preeclampsia: diagnosis and prognosis.

Authors:  Alia A El Shahaway; Rasha R Abd Elhady; Amr Ahmed Abdelrhman; Shymaa Yahia
Journal:  J Inflamm Res       Date:  2019-07-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.